Αναζήτηση | ULYSTAR – Social Networking App, Professional...

μοιράστηκε ένα σύνδεσμο

2025-11-08 05:51:07 -

The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is projected to grow from US$2.61 billion in 2024 to US$5.88 billion by 2033, expanding at a strong CAGR of 9.46%

Growing adoption of advanced cell and gene therapies across the healthcare sector

Read full report: https://www.renub.com/us-cell-gene-therapy-third-party-logistics-market-p.php

#CellTherapy #GeneTherapy #BiopharmaLogistics #ColdChain #HealthcareInnovation #PharmaSupplyChain #3PL #Biotech #USTherapyMarket #RenubResearch

🇺🇸 The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is projected to grow from US$2.61 billion in 2024 to US$5.88 billion by 2033, expanding at a strong CAGR of 9.46% 📈 Growing adoption of advanced cell and gene therapies across the healthcare sector 🔗 Read full report: 👉 https://www.renub.com/us-cell-gene-therapy-third-party-logistics-market-p.php 📊 #CellTherapy #GeneTherapy #BiopharmaLogistics #ColdChain #HealthcareInnovation #PharmaSupplyChain #3PL #Biotech #USTherapyMarket #RenubResearch

WWW.RENUB.COM

U.S. Cell & Gene Therapy 3PL Market Outlook 2025

U.S. Cell and Gene Therapy Third-Party Logistics Market is expected to reach US$ 5.88 billion by 2033 from US$ 2.61 billion in 2024, CAGR of 9.46% from 2025 to 2033.

0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση